Uterus Clinical Trials

• Biobank Uterus Carcinoma
  ClinicalTrials.gov Identifier: NCT00157469 - Recruiting
  Uterus Cancer
  
• Oxaliplatin and Gemcitabine Followed by Radiation Therapy in the Management of Mixed Mullerian Tumors of the Uterus
  ClinicalTrials.gov Identifier: NCT00476086 - Recruiting
  Mullerian Tumors of the Uterus
  
• Trabectedin in Treating Patients With Advanced, Persistent, or Recurrent Leiomyosarcoma of the Uterus
  ClinicalTrials.gov Identifier: NCT00379145 - Recruiting
  Sarcoma
  
• Dosimetric Analysis of Vaginal Cuff Brachytherapy in Endometrial Carcinoma
  ClinicalTrials.gov Identifier: NCT00165126 - Active, not recruiting
  Endometrial Carcinoma; Cervix Cancer; Carcinoma of the Uterus
  
• Combination Chemotherapy Consisting of Pegylated Liposomal Doxorubicin and Carboplatin in Malignant Gynecologic Tumours
  ClinicalTrials.gov Identifier: NCT00189410 - Active, not recruiting
  Cancer of the Ovary Treated as 2nd Line Therapy; Muellerian Mixed Tumours; Tumours of the Uterus; Cervical Cancers; Non-Epithelial Ovarian Tumours
  
• A Phase II Trial of Adjuvant Radiation Therapy With Ifosfamide and Cisplatin in Patients With MMT of the Uterus
  ClinicalTrials.gov Identifier: NCT00231842 - Recruiting
  Uterine Cancer
  
• Prospective Study Assessing Emotional, Sexual and Quality of Life Concerns Of Women Undergoing Removal of the Cervix Versus Removal of the Uterus,Ovaries and Fallopian Tubes For Treatment Of Early Stage Cervical Cancer
  ClinicalTrials.gov Identifier: NCT00579787 - Active, not recruiting
  Cervical Cancer
  
• Hormonal Effects on the Uterus and Endometrium
  ClinicalTrials.gov Identifier: NCT00001454 - Recruiting
  Pregnancy
  
• Malignant Mixed Mullerian Tumors (MMMT) of the Uterus
  ClinicalTrials.gov Identifier: NCT00502203 - Recruiting
  Mixed Tumor, Mullerian
  
• Thalidomide in Treating Patients With Recurrent or Persistent Cancer of the Uterus
  ClinicalTrials.gov Identifier: NCT00025220 - Active, not recruiting
  recurrent uterine sarcoma; uterine leiomyosarcoma
  
• Combination Chemotherapy and Filgrastim in Treating Patients With Recurrent or Persistent Cancer of the Uterus
  ClinicalTrials.gov Identifier: NCT00031629 - Active, not recruiting
  recurrent uterine sarcoma; uterine leiomyosarcoma
  
• Antepartum Chronic Epidural Therapy (ACET) to Improve Blood Flow to the Uterus, Placenta and Baby in Pre-Eclampsia and Intrauterine Growth Restriction
  ClinicalTrials.gov Identifier: NCT00197340 - Recruiting
  Pre-Eclampsia; Fetal Growth Retardation
  
• Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the Uterus
  ClinicalTrials.gov Identifier: NCT00002993 - Active, not recruiting
  recurrent uterine sarcoma; stage III uterine sarcoma; stage IV uterine sarcoma
  
• Ifosfamide With or Without Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cancer of the Uterus
  ClinicalTrials.gov Identifier: NCT00003128 - Active, not recruiting
  stage III uterine sarcoma; stage IV uterine sarcoma; recurrent uterine sarcoma; uterine carcinosarcoma
  
• Radiation Therapy or No Further Treatment Following Surgery in Treating Patients With Cancer of the Uterus
  ClinicalTrials.gov Identifier: NCT00002459 - Active, not recruiting
  uterine leiomyosarcoma; uterine carcinosarcoma; stage II uterine sarcoma; Endometrial Stromal Sarcoma; stage I uterine sarcoma
  
• Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the Uterus
  ClinicalTrials.gov Identifier: NCT00002546 - Active, not recruiting
  stage I uterine sarcoma; stage II uterine sarcoma; stage III uterine sarcoma; stage IV uterine sarcoma; uterine carcinosarcoma
  
• A Long-Term Study to Evaluate the Safety of Asoprisnil in the Treatment of Abnormal Uterine Bleeding in Women with Uterine Fibroids
  ClinicalTrials.gov Identifier: NCT00156195 - Completed
  Fibroid Uterus, Leiomyoma, Menorrhagia, Metrorrhagia, Uterine Fibroids
  
• A Long-Term Study to Evaluate the Safety of Asoprisnil in the Treatment of Abnormal Uterine Bleeding in Women with Uterine Fibroids
  ClinicalTrials.gov Identifier: NCT00156208 - Completed
  Fibroid Uterus, Leiomyoma, Menorrhagia, Metrorrhagia, Uterine Fibroids
  
• A Long-Term Study to Evaluate the Safety of Asoprisnil in the Treatment of Abnormal Uterine Bleeding in Women with Uterine Fibroids
  ClinicalTrials.gov Identifier: NCT00156156 - Completed
  Fibroid Uterus, Leiomyoma, Menorrhagia, Metrorrhagia, Uterine Fibroids
  
• Thalidomide in Treating Patients With Recurrent or Persistent Carcinosarcoma of the Uterus
  ClinicalTrials.gov Identifier: NCT00025506 - Recruiting
  recurrent uterine sarcoma; uterine carcinosarcoma
  
• A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Abnormal Uterine Bleeding in Women with Uterine Fibroids
  ClinicalTrials.gov Identifier: NCT00160381 - Completed
  Fibroid Uterus, Leiomyoma, Menorrhagia, Metrorrhagia, Uterine Fibroids
  
• A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Abnormal Uterine Bleeding in Women with Uterine Fibroids
  ClinicalTrials.gov Identifier: NCT00152269 - Completed
  Fibroid Uterus, Leiomyoma, Menorrhagia, Metrorrhagia, Uterine Fibroids
  
• A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Abnormal Uterine Bleeding in Women with Uterine Fibroids
  ClinicalTrials.gov Identifier: NCT00152256 - Completed
  Fibroid Uterus, Leiomyoma, Menorrhagia, Metrorrhagia, Uterine Fibroids
  
• Laparoscopic Surgery or Standard Surgery in Treating Patients With Endometrial Cancer or Cancer of the Uterus
  ClinicalTrials.gov Identifier: NCT00002706 - Active, not recruiting
  stage I endometrial cancer; stage II endometrial cancer; endometrial adenocarcinoma; stage I uterine sarcoma; stage II uterine sarcoma
  
• Sunitinib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus
  ClinicalTrials.gov Identifier: NCT00378911 - Suspended
  Sarcoma
  
• Comparison of Uterine Exteriorization Versus in Situ Repair at Cesarean Section: a Randomized Clinical Trial
  ClinicalTrials.gov Identifier: NCT00550888 - Completed
  Uterus; Cesarean Section; Abdominal Delivery; Suture Techniques
  
• Effects of Raloxifene on the Uterus and Ovaries of Premenopausal Patients
  ClinicalTrials.gov Identifier: NCT00001837 - Completed
  Breast Cancer; Breast Neoplasm
  
• Effects of Arzoxifene on Bone Mass and the Uterus
  ClinicalTrials.gov Identifier: NCT00085956 - Completed
  Postmenopausal Bone Loss
  
• Gemcitabine in Treating Patients With Recurrent or Refractory Cancer of the Uterus
  ClinicalTrials.gov Identifier: NCT00003316 - Completed
  uterine leiomyosarcoma; recurrent uterine sarcoma
  
• Paclitaxel in Treating Patients With Recurrent or Persistent Cancer of the Uterus
  ClinicalTrials.gov Identifier: NCT00003054 - Completed
  uterine leiomyosarcoma; recurrent uterine sarcoma
  
• Topotecan in Treating Patients With Recurrent or Refractory Cancer of the Uterus
  ClinicalTrials.gov Identifier: NCT00003156 - Completed
  recurrent uterine sarcoma; uterine carcinosarcoma
  
• Combination Chemotherapy Plus Sargramostim in Treating Patients With Cancer of the Uterus
  ClinicalTrials.gov Identifier: NCT00033644 - Completed
  stage IV uterine sarcoma; recurrent uterine sarcoma; uterine leiomyosarcoma
  
• Chemotherapy in Treating Patients With Sarcoma of the Uterus
  ClinicalTrials.gov Identifier: NCT00005643 - Completed
  uterine leiomyosarcoma; recurrent uterine sarcoma; uterine carcinosarcoma; stage IV uterine sarcoma; Endometrial Stromal Sarcoma